RU2010102983A - PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL USE TO INCREASE THE ACTIVITY OF MEDICINES AND REDUCE THEIR SIDE EFFECTS - Google Patents
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL USE TO INCREASE THE ACTIVITY OF MEDICINES AND REDUCE THEIR SIDE EFFECTS Download PDFInfo
- Publication number
- RU2010102983A RU2010102983A RU2010102983/15A RU2010102983A RU2010102983A RU 2010102983 A RU2010102983 A RU 2010102983A RU 2010102983/15 A RU2010102983/15 A RU 2010102983/15A RU 2010102983 A RU2010102983 A RU 2010102983A RU 2010102983 A RU2010102983 A RU 2010102983A
- Authority
- RU
- Russia
- Prior art keywords
- composition according
- composition
- nanosomes
- liposomes
- lecithin
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
1. Фосфолипидная эмульсия, включающая липосомы (наносомы) со средним диаметром липосом (наносом) от 20 до 500 нм, характеризующаяся тем, что липосомы (наносомы) имеют структуру, приближенную по строению к биологическим мембранам, при следующем оптимально подобранном соотношении компонентов липосом, мас.% (на 100 мас.%): ! Этанол 1,0-30,0 Фосфолипиды (лецитин) (с содержанием фосфатидилхолина не менее 60%) 1,0-30,0 Вода до 100,00 ! 2. Композиция по п.1, отличающаяся тем, что дополнительно содержит по меньшей мере, биологически активный компонент и/или один фармакологически активный агент (фармацевтическую субстанцию) ! 3. Композиция любому из пп.1 и 2, содержащая по крайней мере один приемлемый вспомогательный компонент в качестве разбавителя. ! 4. Композиция по любому из пп.1 и 2, отличающаяся тем, что может быть использована для получения лекарственного средства, биологически активной добавки к пище, пищевого продукта питания. ! 5. Композиция по п.2, отличающаяся тем, что композиция позволяет дозировать фармакологически активный компонент в эффективных количествах и ограничивать их верхний предел. ! 6. Композиция по п.1, характеризующаяся тем, что для получения наносом используется лецитин с содержанием фосфатидилхолина не менее 60% для регулирования гибкости, подвижности, проницательной способности и стабильности композиции. ! 7. Композиция по любому из пп.2, 5, 6, характеризующаяся тем, что мембраны липосом позволяют включать в липосомы (наносомы) биологически активные вещества и/или лекарственные вещества вне зависимости от их свойств и растворимости, в том числе гидрофобные и/или гидрофильные вещества. ! 8. Композиция по � 1. Phospholipid emulsion, including liposomes (nanosomes) with an average diameter of liposomes (nanosomes) from 20 to 500 nm, characterized in that the liposomes (nanosomes) have a structure close in structure to biological membranes, with the following optimally selected ratio of liposome components, wt .% (per 100 wt.%):! Ethanol 1.0-30.0 Phospholipids (lecithin) (with a phosphatidylcholine content of at least 60%) 1.0-30.0 Water up to 100.00! 2. The composition according to claim 1, characterized in that it further comprises at least a biologically active component and / or one pharmacologically active agent (pharmaceutical substance)! 3. The composition of any one of claims 1 and 2, containing at least one acceptable auxiliary component as a diluent. ! 4. The composition according to any one of claims 1 and 2, characterized in that it can be used to obtain a medicinal product, biologically active food additives, food product. ! 5. The composition according to claim 2, characterized in that the composition allows you to dose the pharmacologically active component in effective amounts and limit their upper limit. ! 6. The composition according to claim 1, characterized in that to obtain nanosomes, lecithin is used with a phosphatidylcholine content of at least 60% to regulate the flexibility, mobility, penetration and stability of the composition. ! 7. The composition according to any one of claims 2, 5, 6, characterized in that the liposome membranes allow the inclusion of biologically active substances and / or medicinal substances in liposomes (nanosomes), regardless of their properties and solubility, including hydrophobic and / or hydrophilic substances. ! 8. Composition by �
Claims (23)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010102983/15A RU2469706C2 (en) | 2010-01-29 | 2010-01-29 | Pharmaceutical composition for transdermal application for increase of drug activity and decrease of side effects |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010102983/15A RU2469706C2 (en) | 2010-01-29 | 2010-01-29 | Pharmaceutical composition for transdermal application for increase of drug activity and decrease of side effects |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010102983A true RU2010102983A (en) | 2011-08-10 |
RU2469706C2 RU2469706C2 (en) | 2012-12-20 |
Family
ID=44754060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010102983/15A RU2469706C2 (en) | 2010-01-29 | 2010-01-29 | Pharmaceutical composition for transdermal application for increase of drug activity and decrease of side effects |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2469706C2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6764693B1 (en) * | 1992-12-11 | 2004-07-20 | Amaox, Ltd. | Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
RU2135161C1 (en) * | 1998-09-22 | 1999-08-27 | Марцинкевич Ольга Николаевна | Composition "ritsiniol" for cure and cosmetic care of mucous membranes, skin and hair |
RU2236845C2 (en) * | 2002-04-17 | 2004-09-27 | Ставропольское научно-производственное объединение "Пульс" | Anti-burning gel and method for its preparing |
RU2217128C1 (en) * | 2002-07-16 | 2003-11-27 | Закрытое акционерное общество "АИП-Наука" | Preparation for topical application in treatment of pulmonary tuberculosis and suppurative-inflammatory diseases |
RU2315593C1 (en) * | 2006-08-02 | 2008-01-27 | Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" | Antioxidant liposomal composition fir inhalation in lung and upper respiratory tract diseases |
RU2369383C2 (en) * | 2007-10-30 | 2009-10-10 | Общество с ограниченной ответственностью "Научная Компания "Фламена" | Phospholipid suspension containing dihydroquercetin and method for producing |
-
2010
- 2010-01-29 RU RU2010102983/15A patent/RU2469706C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2469706C2 (en) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Natsheh et al. | Phospholipid vesicles for dermal/transdermal and nasal administration of active molecules: The effect of surfactants and alcohols on the fluidity of their lipid bilayers and penetration enhancement properties | |
KR100617929B1 (en) | Stable solution of reduced coenzyme q | |
JP6814148B2 (en) | Emulsion for parenteral administration | |
ES2910085T3 (en) | Semisolid aqueous pharmaceutical composition containing tapentadol | |
ES2745024T3 (en) | Pharmaceutical composition of S-ketamine hydrochloride | |
EP2720701B1 (en) | Therapeutic application of parenteral krill oil | |
KR20160032120A (en) | Self-emulsifying composition of ω-3 fatty acid | |
CN105142631A (en) | Cancer drug and uses | |
KR20190129059A (en) | Pharmaceutical composition | |
US8936803B2 (en) | Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof | |
Ghosh et al. | Recent advancements in nanocarrier based therapy against Acne: The role of biosurfactants and status of patents | |
KR20070058608A (en) | Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy | |
RU2010102983A (en) | PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL USE TO INCREASE THE ACTIVITY OF MEDICINES AND REDUCE THEIR SIDE EFFECTS | |
RU2012144777A (en) | INJECTION EMULSION OF SEDATIVE CURRICULAR AGENT | |
US20150306072A1 (en) | Composition comprising melatonin or its derivatives with coenzyme q10 and use thereof against ageing of the skin | |
JP2015516454A (en) | Vesicle formulation kit and use | |
JP2015516453A (en) | Use and methods of vesicle formulations | |
ES2666836T3 (en) | Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration | |
JP6503627B2 (en) | Pharmaceutical liquid composition | |
US20140120171A1 (en) | Therapeutic application of parenteral krill oil | |
RU2580292C2 (en) | Non-aqueous oil-base injectable composition exhibiting antiseptic efficacy | |
KR20160068302A (en) | Antibacterial or conservative composition containing polyglycerine-3 | |
Salerno et al. | Novel gel-like microemulsion for topical delivery of Amphotericin B | |
CN113784707A (en) | Artificial tear | |
JP2014208617A (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140130 |